165 related articles for article (PubMed ID: 10928151)
1. p53 as an indicator of lymph node metastases in invasive early colorectal cancer.
Makino M; Yamane N; Taniguchi T; Honboh T; Kurayoshi K; Kaibara N
Anticancer Res; 2000; 20(3B):2055-9. PubMed ID: 10928151
[TBL] [Abstract][Full Text] [Related]
2. The relation between p53 overexpression and lymph node metastases in clinical stage t2 and t3a transitional cell bladder carcinoma.
Uygur MC; Yaman I; Kutluay L; Altuğ U; Erol D
J Exp Clin Cancer Res; 1999 Sep; 18(3):391-5. PubMed ID: 10606186
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
4. Involvement of cyclooxygenase-2 and vascular endothelial growth factor in vascularization and lymph node metastasis of colorectal cancers with submucosal invasion.
Abe A; Fukui H; Fujii S; Fujita M; Mukawa K; Ichikawa K; Tomita S; Ono Y; Imai Y; Imura J; Kubota K; Fujimori T
J Gastroenterol Hepatol; 2007 Jul; 22(7):1071-7. PubMed ID: 17608853
[TBL] [Abstract][Full Text] [Related]
5. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
6. Does p53 overexpression cause metastases in early invasive colorectal adenocarcinoma?
Sory A; Minamoto T; Ohta T; Yamashita K; Sawaguchi K; Mai M; Misiuna P
Eur J Surg; 1997 Sep; 163(9):685-92. PubMed ID: 9311476
[TBL] [Abstract][Full Text] [Related]
7. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
8. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
[TBL] [Abstract][Full Text] [Related]
9. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
[TBL] [Abstract][Full Text] [Related]
10. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
[TBL] [Abstract][Full Text] [Related]
11. Tumour 'budding' and its relationship to p53 and Bcl-2 expression in colorectal cancer.
Guzińska-Ustymowicz K; Sulkowska M; Famulski W; Sulkowski S
Anticancer Res; 2003; 23(1B):649-53. PubMed ID: 12680162
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of p53 and p27 proteins, alone or combined, as a predictor of metastatic potential in early invasive carcinoma of colon and rectum--a comparative clinicopathologic and molecular analysis.
Hirano K; Minamoto T
Cancer Detect Prev; 2000; 24(4):343-55. PubMed ID: 11059565
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection.
Yasuda K; Inomata M; Shiromizu A; Shiraishi N; Higashi H; Kitano S
Dis Colon Rectum; 2007 Sep; 50(9):1370-6. PubMed ID: 17661146
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
[TBL] [Abstract][Full Text] [Related]
15. Association of angiogenesis markers with lymph node metastasis in early colorectal cancer.
Iddings DM; Koda EA; Grewal SS; Parker R; Saha S; Bilchik A
Arch Surg; 2007 Aug; 142(8):738-44; discussion 744-5. PubMed ID: 17709727
[TBL] [Abstract][Full Text] [Related]
16. [Effect of overexpression of P53 protein in colorectal carcinoma on short-term prognosis].
Domínguez Iglesias F; Riera Velasco JR; Junco Petrement P; Tojo Ramallo P; Díaz-Faes Cervero M
Rev Esp Enferm Dig; 1994 Nov; 86(5):796-802. PubMed ID: 7848689
[TBL] [Abstract][Full Text] [Related]
17. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question.
Cabanillas R; Rodrigo JP; Astudillo A; Domínguez F; Suárez C; Chiara MD
Cancer; 2007 May; 109(9):1791-8. PubMed ID: 17380529
[TBL] [Abstract][Full Text] [Related]
18. Micropapillary component in colorectal carcinoma is associated with lymph node metastasis in T1 and T2 Stages and decreased survival time in TNM stages I and II.
Xu F; Xu J; Lou Z; Di M; Wang F; Hu H; Lai M
Am J Surg Pathol; 2009 Sep; 33(9):1287-92. PubMed ID: 19471152
[TBL] [Abstract][Full Text] [Related]
19. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
Yano H; Saito Y; Kirihara Y; Takashima J
Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
[TBL] [Abstract][Full Text] [Related]
20. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
